Labcorp vs Tigermed

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/labcorp/tigermedgrp

Category	Labcorp	Tigermed
Listed site	cro	cro
Summary	Global life sciences and healthcare company providing diagnostic testing, drug development services, nonclinical research, and central laboratory services to biopharma companies, healthcare providers, and patients.	Leading global CRO providing end-to-end clinical trial services, preclinical development, medical device and IVD trials, regulatory affairs, and real-world evidence studies across 180+ offices serving 4,000+ customers.
Services	Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Central Laboratory Services Clinical Operations Bioanalysis LC-MS Bioanalysis (Small Molecule) Ligand-Binding Bioanalysis (Large Molecule) Biomarker Assays Immunogenicity Assays (ADA / NAb) Flow Cytometry Services GLP Toxicology Safety Pharmacology In Vitro ADME / DMPK In Vitro Pharmacology Preclinical In Vitro Studies In Vivo PK / PD Studies In Vivo Efficacy Models Preclinical In Vivo Studies Genetic Toxicology Specialized & Large-Animal Models Translational Research Genomics & Sequencing Services Pathology & Histology Services Companion Diagnostics Development Biostatistics & Statistical Programming Data Management & eClinical US FDA Regulatory Strategy EU EMA Regulatory Strategy Regulatory Affairs Medical Writing Oncology Specialty Services Cardiovascular & Metabolic Specialty Services CNS Specialty Services Immunology & Inflammation Services Virology Services Microbiology Services	Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Clinical Operations Clinical Trial Services Clinical Imaging Core Lab Central Laboratory Services Medical Writing Pharmacovigilance & Drug Safety Biostatistics & Statistical Programming Data Management & eClinical Regulatory Affairs US FDA Regulatory Strategy EU EMA Regulatory Strategy China NMPA Regulatory Strategy Japan PMDA Regulatory Strategy Device & Combination Product Services Translational Research GLP Toxicology In Vitro ADME / DMPK In Vitro Pharmacology Preclinical In Vitro Studies In Vivo PK / PD Studies In Vivo Efficacy Models Preclinical In Vivo Studies Bioanalysis LC-MS Bioanalysis (Small Molecule) Ligand-Binding Bioanalysis (Large Molecule) Medicinal Chemistry High-Throughput Screening Oncology Specialty Services Cardiovascular & Metabolic Specialty Services CNS Specialty Services Immunology & Inflammation Services Virology Services Microbiology Services
Modalities	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Cell Therapy Gene Therapy Vaccine Radiopharmaceutical	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Vaccine Cell Therapy Gene Therapy Radiopharmaceutical Oligonucleotide Peptide
Indications	Oncology Neurology Cardiovascular Immunology Infectious Disease Rare Disease Metabolic Respiratory Psychiatry Women's Health	Oncology Cardiovascular Neurology Immunology Infectious Disease Rare Disease Metabolic Ophthalmology Gastroenterology Respiratory
Locations	Global Operations, Global	Headquarters, Hangzhou, Zhejiang, China Global Offices, Multiple, Global, Multiple (180+ locations across 5 continents)
Certifications	Data not yet provided.	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.